Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Despite conclusive evidence that it’s one of the most dangerous and addictive substances in the world, sugar is still widely used for a variety of purposes. In an effort to curb the effects of this sweet food, substitutes like aspartame have been introduced. Naturally, there were concerns about its supposed effects on health, but a recent study found that there were no causes for concern.
Recently published in The Journal of Nutrition, researchers basically looked into the effects of aspartame on several factors of health. These included glucose tolerance, weight, and appetite. The results indicated that the sugar substitute basically had no negative impact on any of those factors.
“With the exception of the baseline OGTT glucose concentration at 60 min (and resulting area under the curve value), there were no group differences for glucose, insulin, resting leptin, glucagon-like peptide 1, or gastric inhibitory peptide at baseline or week 12,” the results of the study reads. “There also were no effects of aspartame ingestion on appetite, body weight, or body composition.”
The study lasted for 12 weeks from start to finish, and throughout that period, the subjects were divided into three groups. One group took no aspartame while another took 350 mg per day. The third group took a much higher dosage of 1,050 mg of the sugar substitute.
Blood samples were taken from the subjects before the start of the trial and at the end of the 12-week course. Apparently, the participants did not show any significant differences in the factors that the researchers were looking at. In conclusion, the researchers note that their findings do not support the notion that aspartame comes with negative consequences such as obesity and an increase in rates of hunger.
On the other hand, Medical News Bulletin did note that the study received support from Ajinomoto Co., Inc., which produces products such as artificial sweeteners. However, the authors of the study insist that the findings of their aspartame research were not affected by the source of the funds.
